Joshua M Eizen insider trades: AN2 Therapeutics (ANTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joshua reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | ANTX | ↓ Sell | 5,945 | $4.17 | $25K | Direct | Jul 10, 2026 (2d) |
| Jan 6, 2026 | ANTX | ↓ Sell | 24,854 | $1.00 | $25K | Direct | Jan 7, 2026 (1d) |
| Nov 4, 2025 | ANTX | ↓ Sell | 2,819 | $1.14 | $3K | Direct | Nov 6, 2025 (2d) |
| Jan 3, 2025 | ANTX | ↓ Sell | 9,663 | $1.34 | $13K | Direct | Jan 7, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANTX insiders
Open-market trades in the last 12 months
About Joshua M Eizen's insider trades
Joshua M Eizen is See Remarks at AN2 Therapeutics (ANTX). Since Jan 3, 2025, Joshua has reported no open-market purchases and 4 sales worth $66K on SEC Form 4. In the last 12 months: 2 sales ($50K).
Their filings also include grants and awards (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.